Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

Documents similaires

• Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
  par: Lashley, D, et autres
  Publié: (2010)
• EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
  par: Lashley, D, et autres
  Publié: (2009)
• Clinical features of the DOK7 neuromuscular junction synaptopathy.
  par: Palace, J, et autres
  Publié: (2007)
• The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
  par: Beeson, D, et autres
  Publié: (2012)
• The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells
  par: Spearman, H, et autres
  Publié: (2008)